July 23, 2015 9:00am
A drop in the bucket for CLBS (the former NBS <NeoStem>) in what it needs and it joins a long list of companies focused on restoring vision with research is still very early using human-induced pluripotent stem cells in a new model of “rodent” retinal degeneration – still an animal model.
Members only. Please login.